Ex vivo expansion of haemopoietic progenitor cells

被引:14
作者
Alcorn, MJ
Holyoake, TL
机构
[1] Leukaemia Research Fund Laboratories, Department of Haematology, Glasgow Royal Infirmary
关键词
D O I
10.1016/S0268-960X(96)90023-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over the last few years, techniques have become available that allow the extensive proliferation of haemopoietic progenitor cells in ex vivo culture systems. The most commonly used method involves a simple liquid suspension culture system supplemented with a range of cytokines. Alternatively, more complex systems have been devised in which the formation of a stromal layer is required. Large increases in total cell numbers and committed progenitor cells can be readily obtained and, with some techniques, significant expansion of primitive haemopoietic cells has been demonstrated. Although these strategies have several potential applications, few clinical studies have been performed. It has been shown that infusion of ex vivo cultured cells is well tolerated with no associated toxicity. However, it is still unclear whether these culture systems sustain sufficient numbers of long-term repopulating cells to secure durable engraftment following myeloablative therapy. In gene therapy studies, ex vivo expansion of stem cells should improve the efficiency of gene transduction to enable the production of genetically modified cells that are capable of expressing the gene of interest for extended periods of time.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 80 条
  • [61] Silva MRG, 1995, EXP HEMATOL, V23, P1676
  • [62] SILVER SM, 1993, BLOOD, V82, pA297
  • [63] STK-1, THE HUMAN HOMOLOG OF FLK-2/FLT-3, IS SELECTIVELY EXPRESSED IN CD34(+) HUMAN BONE-MARROW CELLS AND IS INVOLVED IN THE PROLIFERATION OF EARLY PROGENITOR STEM-CELLS
    SMALL, D
    LEVENSTEIN, M
    KIM, E
    CAROW, C
    AMIN, S
    ROCKWELL, P
    WITTE, L
    BURROW, C
    RATAJCZAK, MZ
    GEWIRTZ, AM
    CIVIN, CI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 459 - 463
  • [64] SROUR EF, 1993, BLOOD, V81, P661
  • [65] Generation of human dendritic cells Langerhans cells from circulating CD34(+) hematopoietic progenitor cells
    Strunk, D
    Rappersberger, K
    Egger, C
    Strobl, H
    Kromer, E
    Elbe, A
    Maurer, D
    Stingl, G
    [J]. BLOOD, 1996, 87 (04) : 1292 - 1302
  • [66] QUANTITATIVE ASSAY FOR TOTIPOTENT RECONSTITUTING HEMATOPOIETIC STEM-CELLS BY A COMPETITIVE REPOPULATION STRATEGY
    SZILVASSY, SJ
    HUMPHRIES, RK
    LANSDORP, PM
    EAVES, AC
    EAVES, CJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) : 8736 - 8740
  • [67] Generation of human natural killer cells from peripheral blood CD34(+) cells mobilized by granulocyte colony-stimulating factor
    Takenaka, K
    Mizuno, S
    Harada, M
    Nagafuji, K
    Miyamoto, T
    Iwasaki, H
    Fujisaki, T
    Kubota, A
    Ohno, Y
    Arima, F
    Shigematsu, H
    Gondo, H
    Okamura, T
    Okamura, S
    Inaba, S
    Niho, Y
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) : 788 - 794
  • [68] TAVASSOLI M, 1980, BLOOD PURE ELOQUENT, P57
  • [69] TO LB, 1994, BLOOD, V84, P2930
  • [70] EVALUATION OF EX-VIVO EXPANSION POTENTIAL OF CORD-BLOOD AND BONE-MARROW HEMATOPOIETIC PROGENITOR CELLS USING CELL TRACKING AND LIMITING DILUTION ANALYSIS
    TRAYCOFF, CM
    KOSAK, ST
    GRIGSBY, S
    SROUR, EF
    [J]. BLOOD, 1995, 85 (08) : 2059 - 2068